Department of Animal and Food Sciences, University of Delaware, Newark, DE 19716, USA.
Department of Animal and Comparative Biomedical Sciences, The University of Arizona, Tucson, AZ 85721, USA.
Genes (Basel). 2019 Feb 5;10(2):116. doi: 10.3390/genes10020116.
Marek's disease virus (MDV) is the causative agent of Marek's disease (MD), a complex pathology of chickens characterized by paralysis, immunosuppression, and T-cell lymphomagenesis. MD is controlled in poultry production via vaccines administered or at hatch, and these confer protection against lymphoma formation, but not superinfection by MDV field strains. Despite vaccine-induced humoral and cell-mediated immune responses, mechanisms eliciting systemic protection remain unclear. Here we report the contents of serum exosomes to assess their possible roles as indicators of systemic immunity, and alternatively, tumor formation. We examined the RNA and protein content of serum exosomes from CVI988 (Rispens)-vaccinated and protected chickens (VEX), and unvaccinated tumor-bearing chickens (TEX), via deep-sequencing and mass spectrometry, respectively. Bioinformatic analyses of microRNAs (miRNAs) and predicted miRNA targets indicated a greater abundance of tumor suppressor miRNAs in VEX compared to TEX. Conversely, oncomiRs originating from cellular (miRs 106a-363) and MDV miRNA clusters were more abundant in TEX compared to VEX. Most notably, mRNAs mapping to the entire MDV genome were identified in VEX, while mRNAs mapping to the repeats flanking the unique long (IR/TR) were identified in TEX. These data suggest that long-term systemic vaccine-induced immune responses may be mediated at the level of VEX which transfer viral mRNAs to antigen presenting cells systemically. Proteomic analyses of these exosomes suggested potential biomarkers for VEX and TEX. These data provide important putative insight into MDV-mediated immune suppression and vaccine responses, as well as potential serum biomarkers for MD protection and susceptibility.
马立克氏病病毒(MDV)是马立克氏病(MD)的病原体,MD 是一种复杂的鸡病,其特征为瘫痪、免疫抑制和 T 细胞淋巴瘤发生。MD 可通过在禽生产中接种疫苗或孵化时接种疫苗来控制,这些疫苗可预防淋巴瘤的形成,但不能预防 MDV 田间株的再感染。尽管疫苗诱导了体液和细胞介导的免疫反应,但引发全身保护的机制仍不清楚。在这里,我们报告了血清外泌体的内容,以评估它们作为全身免疫指标的可能性,或者作为肿瘤形成的指标。我们通过深度测序和质谱法分别检查了 CVI988(Rispens)疫苗接种和保护的鸡(VEX)以及未接种肿瘤的鸡(TEX)的血清外泌体的 RNA 和蛋白质含量。对外泌体中 microRNAs(miRNAs)和预测的 miRNA 靶标的生物信息学分析表明,VEX 中的肿瘤抑制 miRNA 丰度高于 TEX。相反,源自细胞的致癌 miRNA(miRs 106a-363)和 MDV miRNA 簇的致癌 miRNA 在 TEX 中的丰度高于 VEX。值得注意的是,在 VEX 中鉴定到了与整个 MDV 基因组映射的 mRNAs,而在 TEX 中鉴定到了与独特的长(IR/TR)侧翼重复序列映射的 mRNAs。这些数据表明,长期的系统疫苗诱导的免疫反应可能是由 VEX 介导的,VEX 将病毒 mRNAs 转移到全身的抗原呈递细胞中。这些外泌体的蛋白质组学分析表明了 VEX 和 TEX 的潜在生物标志物。这些数据为 MDV 介导的免疫抑制和疫苗反应提供了重要的假设性见解,以及 MD 保护和易感性的潜在血清生物标志物。